FDA Slap Down Makes for Greater Gains
Biogen’s promising Alzheimer’s treatment looked like it was all set for approval. Then, in a wild turn of events, the FDA panel voted no on approving it for treatment. Ironically, the slap down only led to greater gains for Denali!
You Must Be A Subscriber To View This Content.
If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication below and get access today!
Breakthrough Technology Alert
This is the best time to be investing in world-changing technologies, as unprecedented innovations are taking off right now… Breakthrough Technology Alert tirelessly researches these exciting new breakthrough technologies to keep you well informed, outline specific opportunities, and keep you ahead of the game.